The
global chronic obstructive pulmonary disease devices market is expected to
display rising growth in forthcoming period. Chronic Obstructive Pulmonary
Disease (COPD) is an acute disease of the lungs bordering on emphysema, chronic
bronchitis, refractory asthma and some offshoots of bronchiectasis.
Chronic
Obstructive Pulmonary Disease is annotated by increasing breathlessness,
wheezing and constriction in the chest. The disease in early stages may not
come up with these complications but the symptoms gradually make themselves
felt at later stages. Breathing difficulty, bout of cough, fatigue and flu,
weight loss are the symptoms seen in later stages. The tests undertaken to
diagnose COPD are Spirometry, chest X-ray and arterial blood gas test. The
common factors causing occurrence of COPD are smoking, genetic factors and
environmental pollution. Segmentation of chronic obstructive pulmonary disease
devices market by product include oxygen therapy system, blood gas monitoring
system, accessories and spirometry testing products. Segmentation of chronic
obstructive pulmonary disease devices market by test type includes Lung
functional test, chest X-Ray test, CT scan and others.
Browse Full Report With TOC @ https://www.millioninsights.com/industry-reports/chronic-obstructive-pulmonary-disease-copd-devices-market
Rapid
advances in drug delivery, increasing disposable incomes and rising spend on
personal healthcare with large incidences of COPD in MEA during forecast
period. The lung functional test also called spirometry test is a convenient
function to test respiration by lungs and lung capacity. Among the uses of
specific drugs, oral corticosteroid segment is likely to display magnanimous
growth over forecast period. The key players operating in the chronic
obstructive pulmonary disease devices includes Boehringer Ingelheim, Teva
Pharmaceutical Industries, Novartis AG and Bayer AG, Astra Zenca, Actrlion
Pharmaceuticals, Inc, and Inc Sunovian Pharmaceuticals.
Segmentation
of chronic obstructive pulmonary disease by end-use/application includes
hospital, ASCs and Home Care. By geographical regions, segmentation of chronic
obstructive pulmonary disease includes North America, Europe, Asia Pacific, MEA
and Latin America. North America is foremost in COPD market because of high use
of drugs in treatment of COPD and complete information regarding treatment.
Market Segment:
Geographically, this report is segmented
into several key Regions, with production, consumption, revenue (million USD),
market share and growth rate of Chronic Obstructive Pulmonary Disease Devices
in these regions, from 2012 to 2022 (forecast), covering
•
North America
•
Europe
•
China
•
Japan
•
Southeast Asia
•
India
Global Chronic Obstructive Pulmonary
Disease Devices market competition by top manufacturers, with production,
price, revenue (value) and market share for each manufacturer; the top players
including
•
Covidien LTD
•
Abbott Laboratories
•
Cardinal Health, Inc.
•
Chart Industries, Inc.
•
AirSep Corporation
•
Teleflex Medical, Inc.
•
Masimo Corporation
View Sample Copy Of this Report @ https://www.millioninsights.com/industry-reports/chronic-obstructive-pulmonary-disease-copd-devices-market/request-sample
No comments:
Post a Comment